10-K: Ascend Wellness Holdings Reports FY2024 Results, Navigates Evolving Cannabis Market

Ascend Wellness Holdings (AWH) reports an 8% revenue increase for FY2024, driven by wholesale expansion and strategic acquisitions, while managing increased competition and evolving regulatory landscapes.

Summary

• Ascend Wellness Holdings, Inc. (AWH) reported an 8% increase in net revenue for the fiscal year ended December 31, 2024, reaching $561.6 million compared to $518.6 million in 2023.
• The revenue growth was primarily driven by a $41.9 million increase in wholesale revenue and $53.7 million from acquisitions, offset by a $52.7 million decrease in revenue from legacy locations due to increased competition.
• The company's operating profit was $4.7 million in 2024, a significant improvement from the $3.6 million operating loss in 2023.
• AWH had 39 open dispensaries as of December 31, 2024, and re-opened its Detroit dispensary in Q1 2025, bringing the total to 40.
• The company is pursuing expansion plans to reach 60 retail locations, including partner locations.
• AWH issued $235 million in senior secured notes due 2029 in July 2024 and used the proceeds to prepay $215 million of existing debt.
• In January 2025, AWH issued an additional $15 million of term notes for general corporate purposes.
• The company is subject to the limitations of Internal Revenue Code (IRC) Section 280E, which prohibits businesses from deducting certain expenses associated with trafficking controlled substances.
• AWH has filed amended tax returns with the IRS claiming refunds of tax for 2020 and 2021 and a refund and/or reduction of tax for 2022 based on a legal interpretation that Section 280E does not apply to solely intrastate cannabis-related business activities.
• As of December 31, 2024, AWH had approximately 2,300 employees, with approximately 29% represented by collective bargaining agreements.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While revenue increased and operating profit improved, the net loss widened, and the company faces regulatory and competitive challenges. The company's ability to manage its capital structure and execute its expansion plans will be critical.

Positives

• Significant improvement in operating profit, moving from a loss to a profit year-over-year.
• Increase in wholesale revenue, indicating successful expansion in key markets.
• Strategic acquisitions contributing to revenue growth.
• Expansion of retail footprint with new store openings.
• Successful debt refinancing to manage capital structure.

Negatives

• Decrease in revenue from legacy locations due to increased competition.
• Continued impact from IRC Section 280E, limiting tax deductions.
• Ongoing legal proceedings, such as the MedMen NY litigation, which require resources and attention.
• The company has an accumulated deficit of $400.4 million as of December 31, 2024.

Risks

• Cannabis remains illegal under U.S. federal law, creating regulatory uncertainty.
• The company faces intense competition from other cannabis operators.
• There are potential difficulties in enforcing contracts due to the federal illegality of cannabis.
• The company is subject to security risks, including theft and cyber-attacks.
• There are potential product liability claims and other litigation risks.
• The company may face limitations on ownership of cannabis licenses in certain states.
• The market price for the shares of Class A common stock may be volatile.

Future Outlook

The company expects continued growth to be driven by opening new dispensaries under current licenses and through partnership opportunities, expansion of current cultivation facilities, and increased consumer demand. AWH anticipates capital expenditures, net of tenant improvement allowances, of approximately $30 million to $35 million during 2025.

Management Comments

• Management believes that substantial doubt of our ability to continue as a going concern for at least one year from the issuance of our Financial Statements has been alleviated due to: (i) cash on hand and (ii) continued growth of sales from our consolidated operations.
• Management plans to continue to access capital markets for additional funding through debt and/or equity financings to supplement future cash needs, as may be required.

Industry Context

The announcement reflects the ongoing challenges and opportunities in the cannabis industry, including navigating regulatory complexities, managing competition, and securing capital. The company's focus on limited-license markets and vertical integration aligns with strategies employed by other multi-state operators (MSOs) to achieve sustainable growth.

Comparison to Industry Standards

• Comparable companies like Trulieve, Curaleaf, and Green Thumb Industries also operate in multiple states and face similar regulatory and competitive pressures.
• AWH's gross margin of 32.8% is within the range of other MSOs, but can vary based on state-level regulations and market dynamics.
• The company's focus on vertical integration, aiming for 50% of retail sales from in-house products, is a common strategy to improve margins, similar to that of companies like Cresco Labs.
• The company's expansion strategy of targeting limited-license, late-stage medical markets with an anticipated adult-use cannabis market launch is similar to strategies employed by TerrAscend and Ayr Wellness.

Legal Proceedings

• The Company is involved in ongoing litigation with MedMen NY, Inc. regarding a terminated investment agreement.

Related Party Transactions

• The Company has a loan receivable from a borrower partially owned by an entity managed by one of the founders of the Company.

Stakeholder Impact

• Shareholders: The company's performance and strategic decisions will impact shareholder value.
• Employees: The company's growth and financial stability will affect employment opportunities and job security.
• Customers: The company's ability to provide high-quality products and services will impact customer satisfaction.
• Suppliers: The company's financial health will affect its ability to meet its obligations to suppliers.
• Creditors: The company's ability to manage its debt and meet its financial obligations will impact its relationship with creditors.

Next Steps

• Continue to execute expansion plans to reach 60 retail locations.
• Manage capital structure and debt obligations.
• Monitor and adapt to evolving regulatory landscape.
• Pursue strategic initiatives to drive revenue growth and improve profitability.

Key Dates